Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

Thermo, Princeton Work on LC/MS

By Drug Discovery Trends Editor | August 21, 2012

Thermo Fisher Scientific Inc. has entered into a Technology Alliance Partnership agreement with scientists at Princeton University, establishing a formal collaboration to accelerate research in triple quadrupole and high-resolution accurate mass (HRAM) liquid chromatography-mass spectrometry (LCMS) for life science applications.

The agreement, a broad collaboration between Thermo Fisher scientists and Princeton scientists  includes: engaging in research, sharing samples and data that could lead to development of better techniques, exchanging ideas and opinions about improving instrument and software performance, ongoing discourse about current technology issues and publishing new methodologies and scientific advances.  The groups had previously collaborated informally.

The alliance will focus on three research areas:

• Metabolomics, within the laboratory of Joshua Rabinowitz, professor of chemistry at the Lewis Sigler Institute at Princeton.
• Proteomics integrated with Molecular Biology and Infectious Diseases, within the laboratory of Ileana Cristea, assistant professor of molecular biology at Princeton.
• Mass spectrometry/proteomics method development, with David Perlman at the Princeton Mass Spectrometry and Synthesizing / Sequencing Facility.

“Academic research labs are tremendous sources of innovation, which is why we’re so pleased to collaborate with Princeton scientists to pursue new paths toward a healthier world,” said Iain Mylchreest, vice president, Research and Development, Thermo Fisher.

“Thermo Fisher is a leader in mass spectrometry, and their equipment has been instrumental in many discoveries by Princeton scientists,” said professor Rabinowitz. “This agreement formalizes our commitment to interact openly and actively to expedite the development and application of important new technologies.”

“This Technology Alliance Partnership is a welcomed extension of a productive collaboration that my laboratory has had with Thermo Fisher since I joined Princeton,” added professor Cristea. “Examples of these collaborative efforts are the optimization of the MALDI LTQ Orbitrap XL, the use of isobaric tags for quantification of protein interactions and the use of the EASY-Spray technology. This partnership will allow us to expand these collaborative efforts and accelerate the integration of developments in mass spectrometry and important biological discoveries.”

Date: August 13, 2012
Source: Thermo Fisher Scientific Inc.


Filed Under: Drug Discovery

 

Related Articles Read More >

Takeda Pharmaceutical in the Drug Discovery & Development Pharma 50
Takeda’s Takhzyro fares well in pediatric hereditary angioedema study
Novartis in the Pharma 50
Novartis to cut up to 8,000 positions
Gilead Sciences in the Drug Discovery & Development Pharma 50
Gilead resubmits application to FDA for twice-yearly HIV drug lenacapavir
George Floyd mural
How the pandemic and George Floyd made clinical trial diversity a priority

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50